A study for a 62 year old woman who takes Metoprolol Succinate, Levothyroxine Sodium (an AI-powered real world drug study)
Summary:
8,166 females aged 62 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 62 year old female patient who has A-Fib, Hypothyroidism. The study is created by eHealthMe based on reports from sources including the FDA.
8,166 females aged 62 (±5) who take Metoprolol Succinate, Levothyroxine Sodium and have adverse effects are studied.
Number of reports submitted per year:

Information of the patient in this study:
- Age: 62
- Gender: female
What are the drugs?
- Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 66,933 Metoprolol succinate users. Check the latest studies of Metoprolol succinate.
- Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,813 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.
What are the conditions?
- A-fib (most common type of arrhythmia) is found to be associated with 2,875 drugs and 3,842 conditions by eHealthMe. Check the latest studies of A-fib.
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development) is found to be associated with 1,617 drugs and 2,600 conditions by eHealthMe. Check the latest studies of Hypothyroidism.
Common drug interactions *:
- Nausea (feeling of having an urge to vomit): 777 people, 9.52%
- Fatigue (feeling of tiredness): 765 people, 9.37%
- Diarrhea : 699 people, 8.56%
- Dyspnea (difficult or laboured breathing): 551 people, 6.75%
- Pain : 533 people, 6.53%
- Headache (pain in head): 515 people, 6.31%
- Weakness : 512 people, 6.27%
- Dizziness : 485 people, 5.94%
- Acute Kidney Failure : 448 people, 5.49%
- Nausea And Vomiting : 425 people, 5.20%
- Fall : 400 people, 4.90%
- Drug Ineffective : 396 people, 4.85%
- Pneumonia : 372 people, 4.56%
- Chest Pain : 370 people, 4.53%
- Malaise (a feeling of general discomfort or uneasiness): 363 people, 4.45%
- Urinary Tract Infection : 361 people, 4.42%
- Weight Decreased : 355 people, 4.35%
- Joint Pain : 354 people, 4.34%
- Chronic Kidney Disease : 342 people, 4.19%
- Stress And Anxiety : 340 people, 4.16%
Common co-existing conditions *:
You may use this to check any potential undetected conditions.
- High Blood Cholesterol : 847 people, 10.37%
- Pain : 737 people, 9.03%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 734 people, 8.99%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 702 people, 8.60%
- Depression : 571 people, 6.99%
- Diabetes : 436 people, 5.34%
- Stress And Anxiety : 432 people, 5.29%
- Cardiac Disorder : 316 people, 3.87%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 302 people, 3.70%
- Multiple Myeloma (cancer of the plasma cells): 298 people, 3.65%
- Type 2 Diabetes : 294 people, 3.60%
- Nausea (feeling of having an urge to vomit): 214 people, 2.62%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 191 people, 2.34%
- Fibromyalgia (a long-term condition which causes pain all over the body): 189 people, 2.31%
- Sleep Disorder : 184 people, 2.25%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 182 people, 2.23%
- Insomnia (sleeplessness): 176 people, 2.16%
- Asthma : 162 people, 1.98%
- Blood Pressure Abnormal : 153 people, 1.87%
- Hypersensitivity : 153 people, 1.87%
Common co-used drugs *:
You may use this to check any potential interacting drugs.
- Aspirin (887 people, 10.86%)
- Metformin (829 people, 10.15%)
- Lasix (825 people, 10.10%)
- Vitamin D3 (717 people, 8.78%)
- Lipitor (698 people, 8.55%)
- Nexium (670 people, 8.20%)
- Pantoprazole (664 people, 8.13%)
- Amlodipine (652 people, 7.98%)
- Prilosec (552 people, 6.76%)
- Plavix (533 people, 6.53%)
- Vitamin D (532 people, 6.51%)
- Protonix (519 people, 6.36%)
- Lyrica (496 people, 6.07%)
- Humira (478 people, 5.85%)
- Crestor (466 people, 5.71%)
- Lisinopril (455 people, 5.57%)
- Vitamin B12 (433 people, 5.30%)
- Cymbalta (429 people, 5.25%)
- Tylenol (421 people, 5.16%)
- Omeprazole (411 people, 5.03%)
Drug effectiveness *:
Metoprolol Succinate:
- not at all: 0 %
- somewhat: 11.11 %
- moderate: 22.22 %
- high: 38.89 %
- very high: 27.78 %
Levothyroxine Sodium:
- not at all: 0 %
- somewhat: 5.5600000000000005 %
- moderate: 38.89 %
- high: 38.89 %
- very high: 16.67 %
* Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drug side effects in long term, by gender and age:
- Levothyroxine sodium: 129,813 reports
- Metoprolol succinate: 66,933 reports
Treatments, associated medications and conditions:
- A-fib: 349,230 reports
- Hypothyroidism: 168,067 reports
Drug interactions:
- Metoprolol succinate and Levothyroxine sodium drug interaction (3,289 reports)
How the phase IV clinical study uses the data?
The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Otezla and Bupivacaine Hydrochloride - 2 seconds ago
- Drug interactions of Torsemide and Doxycycline - 10 seconds ago
- Chest Pain Aggravated in Fexofenadine Hydrochloride, how severe and when it was recovered? - 13 seconds ago
- Terminal Insomnia and drugs of ingredients of selenium - 16 seconds ago
- Dry Eyes and drugs of ingredients of zoledronic acid - 17 seconds ago
- Lamotrigine and Drug Abuse for Men aged 40-49 - 18 seconds ago
- Lamotrigine and Substance Abuse for Men aged 40-49 - 18 seconds ago
- Lamotrigine and Pcp Abuse for Men aged 40-49 - 18 seconds ago
- Lamotrigine and Narcotic Abuse for Men aged 40-49 - 18 seconds ago
- Lamotrigine and Marijuana Abuse for Men aged 40-49 - 19 seconds ago